Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab.
Patriarca F, Medeot M, Isola M, Battista ML, Sperotto A, Pipan C, Toffoletti E, Dozzo M, Michelutti A, Gregoraci G, Geromin A, Cerno M, Savignano C, Rinaldi C, Barbone F, Fanin R. Patriarca F, et al. Among authors: battista ml. Transpl Infect Dis. 2013 Jun;15(3):259-67. doi: 10.1111/tid.12061. Epub 2013 Feb 13. Transpl Infect Dis. 2013. PMID: 23405972
Low-dose rituximab in adult patients with primary immune thrombocytopenia.
Zaja F, Vianelli N, Volpetti S, Battista ML, Defina M, Palmieri S, Bocchia M, Medeot M, De Luca S, Ferrara F, Isola M, Baccarani M, Fanin R. Zaja F, et al. Among authors: battista ml. Eur J Haematol. 2010 Oct;85(4):329-34. doi: 10.1111/j.1600-0609.2010.01486.x. Epub 2010 Jul 28. Eur J Haematol. 2010. PMID: 20546023 Clinical Trial.
Risk Factors and Outcomes of Infections by Multidrug-Resistant Gram-Negative Bacteria in Patients Undergoing Hematopoietic Stem Cell Transplantation.
Patriarca F, Cigana C, Massimo D, Lazzarotto D, Geromin A, Isola M, Battista ML, Medeot M, Cerno M, Sperotto A, Candoni A, Crapis M, Sartor A, Scarparo C, Bassetti M, Fanin R. Patriarca F, et al. Among authors: battista ml. Biol Blood Marrow Transplant. 2017 Feb;23(2):333-339. doi: 10.1016/j.bbmt.2016.11.005. Epub 2016 Nov 4. Biol Blood Marrow Transplant. 2017. PMID: 27826061 Free article.
Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura.
Zaja F, Battista ML, Pirrotta MT, Palmieri S, Montagna M, Vianelli N, Marin L, Cavallin M, Bocchia M, Defina M, Ippoliti M, Ferrara F, Patriarca F, Avanzini MA, Regazzi M, Baccarani M, Isola M, Soldano F, Fanin R. Zaja F, et al. Among authors: battista ml. Haematologica. 2008 Jun;93(6):930-3. doi: 10.3324/haematol.12206. Epub 2008 Apr 9. Haematologica. 2008. PMID: 18403395 Free article.
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia.
Zaja F, Baccarani M, Mazza P, Bocchia M, Gugliotta L, Zaccaria A, Vianelli N, Defina M, Tieghi A, Amadori S, Campagna S, Ferrara F, Angelucci E, Usala E, Cantoni S, Visani G, Fornaro A, Rizzi R, De Stefano V, Casulli F, Battista ML, Isola M, Soldano F, Gamba E, Fanin R. Zaja F, et al. Among authors: battista ml. Blood. 2010 Apr 8;115(14):2755-62. doi: 10.1182/blood-2009-07-229815. Epub 2010 Feb 3. Blood. 2010. PMID: 20130241 Free article. Clinical Trial.
Erratum to: Risk Factors and Outcomes of Infections by Multidrug-Resistant Gram-Negative Bacteria in Patients Undergoing Hematopoietic Stem Cell Transplantation [Biol Blood Marrow Transplant 2017;23:333-339].
Patriarca F, Cigana C, Dozzo M, Lazzarotto D, Geromin A, Isola M, Battista ML, Medeot M, Cerno M, Sperotto A, Candoni A, Crapis M, Sartor A, Scarparo C, Bassetti M, Fanin R. Patriarca F, et al. Among authors: battista ml. Biol Blood Marrow Transplant. 2017 Jun;23(6):1040. doi: 10.1016/j.bbmt.2017.01.072. Epub 2017 Feb 6. Biol Blood Marrow Transplant. 2017. PMID: 28183535 Free article. No abstract available.
19 results